Medicines Access & Patient-Oriented Services

Medicines Access & Patient-Oriented Services

Supporting medicines access programmes across complex regulatory
and supply environments 

Discuss Your Access Programme

Navigating Access to Medicines Across Global Markets 

Medicines access requirements vary across markets, from regulatory pathways and import procedures to engagement with local authorities. Multi-country programmes require regulatory expertise and reliable supply coordination.

COREX supports companies in implementing Named Patient (NPP), Expanded Access (EAP), Managed Access (MAP), Compassionate Use (CUP), and Post-Trial Access programmes. We assess country requirements, coordinate with local authorities, and manage the compliant supply and distribution of unlicensed medicines.

Whether planning access for an individual patient or implementing a multi-country programme, sponsors can rely on COREX for compliant, efficient delivery and reliable treatment access across 45+ countries, including complex and emerging markets.

What we offer

Managed Access Programme (MAP)

Managed Access Programme (MAP)

Learn more
Named Patient Programme (NPP)

Named Patient Programme (NPP)

Learn more
Expanded Access Programme (EAP)

Expanded Access Programme (EAP)

Learn more
Post-Trial Access (PTA)

Post-Trial Access (PTA)

Learn more
Compassionate Use Programme (CUP)

Compassionate Use Programme (CUP)

Learn more
Patient-Oriented Services

Patient-Oriented Services

Learn more

Why choose COREX
for Medicines Access
& Patient-Oriented Services?

15+ Years of Access Programme Expertise 

Since 2011, COREX has managed access programmes for pharmaceutical and biotech companies from single-patient NPP requests to multi-country MAP rollouts across oncology, rare diseases, and specialty care. 
15+ Years of Access Programme Expertise 

Every Access Pathway Under One Provider 

MAP, NPP, EAP, PTA, and CUP – all types of medicines access programmes supported by one integrated team, eliminating handoffs between vendors and reducing programme complexity for sponsors.
Every Access Pathway Under One Provider 

In-House Regulatory Expertise Across 45+ Countries 

COREX works directly with health authorities, ethics committees, and local regulators across the EU, UK, Ireland, CIS, MENA, and APAC – no outsourcing, no delays in escalation. 
In-House Regulatory Expertise Across 45+ Countries 

Multilingual Local Support

Programme success depends on effective local communication. Our teams support physicians, healthcare providers, and patients with documentation, procedural guidance, and case coordination in local languages. 
Multilingual Local Support

Validated Supply from Ambient to Cryogenic 

Access programmes often involve temperature-sensitive therapies – including biologics, cell and gene therapies, and vaccines. Our validated cold chain supports every temperature range required by modern medicine. 
Validated Supply from Ambient to Cryogenic 

Dedicated Access Programme Manager

Every programme has a single point of contact who coordinates regulators, healthcare providers, logistics partners, and internal sponsor teams – from feasibility to programme close-out. 
 Dedicated Access Programme Manager